Field not found.

Found 1304 Results
Page 80 of 131


McWilliams C, Bonnie K, Robinson S, Johnson C, Puyat JH, Klimas J Preliminary results of psychiatric inpatients referred to an addiction medicine consult service J Addict Med PubMed


Randhawa P, Brar R, Nolan S Buprenorphine-naloxone "microdosing": an alternative induction approach for the treatment of opioid use disorder in the wake of North America's increasingly potent illicit drug market CMAJ PubMed


Weicker S, Hayashi K, Grant C, Milloy MJ, Wood E, Kerr T Willingness to take buprenorphine/naloxone among people who use opioids in Vancouver, Canada Drug Alcohol Depend PubMed


Adams J, Marshall B, Mohd Salleh NA, Barrios R, Nolan S, Milloy MJ Receipt of opioid agonist treatment halves the risk of HIV-1 RNA viral load rebound through improved ART adherence for HIV-infected women who use illicit drugs Drug Alcohol Depend PubMed


Bardwell G, Wood E, Brar R Fentanyl assisted treatment: a possible role in the opioid overdose epidemic? Subst Abuse Treat Prev Policy PubMed


Lake S, Kerr T, Buxton J, Walsh Z, Marshall BDL, Wood E, Milloy MJ Does cannabis use modify the effect of post-traumatic stress disorder on severe depression and suicidal ideation? Evidence from a population-based cross-sectional study of Canadians J Psychopharmacol PubMed


McCrae K, Tobias S, Grant C, Lysyshyn M, Laing R, Wood E, Ti L Assessing the limit of detection of Fourier-transform infrared spectroscopy and immunoassay strips for fentanyl in a real-world setting Drug Alcohol Rev PubMed


Lake S, Walsh Z, Kerr T, Cooper ZD, Buxton J, Wood E, Ware MA, Milloy MJ Frequency of cannabis and illicit opioid use among people who use drugs and report chronic pain: a longitudinal analysis PLoS Med PubMed


Beaulieu T, Hayashi K, Nosova E, Milloy MJ, DeBeck K, Wood E, Kerr T, Ti L Effect of witnessing an overdose on the use of drug checking services among people who use illicit drugs in Vancouver, Canada Am J Drug Alcohol Abuse PubMed


van Draanen J Unique roles of childhood poverty and adversity in the development of lifetime co-occurring disorder SSM Popul Health PubMed


BC Centre on Substance Use
4th Floor, 1190 Hornby Street,
Vancouver BC, V6Z 2K5

E: [email protected] | T: (778) 945-7616

24/7 Addiction Clinician Support Line: (778) 945-7619

ACTOC and POATSP: [email protected]




Copyright © 2026, BC Centre on Substance Use